scholarly journals Erratum

1992 ◽  
Vol 12 (1) ◽  
pp. 177-177
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Liver Disease ◽  
Hepatic Encephalopathy ◽  
Minimal Hepatic Encephalopathy ◽  
Severe Liver ◽  
Ammonia Metabolism ◽  
The Third ◽  
Ph Values ◽  
Severe Liver Disease

Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy Alan H. Lockwood, Eddy W. H. Yap, and Wai-Hoi Wong [Originally published in Journal of Cerebral Blood Flow and Metabolism 1991;11;337–341] [Originally published in Journal of Cerebral Blood Flow and Metabolism 1991;11;337–341] The first sentence of the third paragraph of the Discussion, on page 339, should read as follows: “In aqueous solutions at physiological pH values, about 1–2% of all ammonia exists as a diffusible gas, with the remainder present as the less mobile charged ammoniumion.”

scholarly journals Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy

1991 ◽  
Vol 11 (2) ◽  
pp. 337-341 ◽  
Author(s):  
Alan H. Lockwood ◽  
Eddy W. H. Yap ◽  
Wai-Hoi Wong
Keyword(s):  
Liver Disease ◽  
Hepatic Encephalopathy ◽  
Surface Area ◽  
Blood Brain Barrier ◽  
Minimal Hepatic Encephalopathy ◽  
Severe Liver ◽  
Ammonia Metabolism ◽  
Permeability Surface ◽  
Severe Liver Disease ◽  
Area Product

Cerebral ammonia metabolism was studied in five control subjects and five patients with severe liver disease exhibiting minimal hepatic encephalopathy. The arterial ammonia concentration in the control subjects was 30 ± 7 μmol/L (mean ± SD) and 55 ± 13 μmol/L in the patients (p < 0.01). In the normal subjects, the whole-brain values for cerebral blood flow, cerebral metabolic rate for ammonia, and the permeability-surface area product for ammonia were 0.58 ± 0.12 ml g−1 min−1, 0.35 ± 0.15 μmol 100 g−1 min−1, and 0.13 ± 0.03 ml g−1 min−1, respectively. In the patients, the respective values were 0.46 ± 0.16 ml g−1 min−1 (not different from control), 0.91 ± 0.36 μmol 100 g−1 min−1 (p < 0.025), and 0.22 ± 0.07 ml g−1 min−1 (p < 0.05). The increased permeability-surface area product of the blood-brain barrier permits ammonia to diffuse across the blood-brain barrier into the brain more freely than normal. This may cause ammonia-induced encephalopathy even though arterial ammonia levels are normal or near normal and explain the emergence of toxin hypersensitivity as liver disease progresses. Greater emphasis on early detection of encephalopathy and aggressive treatment of minimal hyperammonemia may retard the development of ammonia-induced complications of severe liver disease.

P452 MORTALITY ASSOCIATED WITH HEPATIC ENCEPHALOPATHY IN PATIENTS WITH SEVERE LIVER DISEASE

2014 ◽  
Vol 60 (1) ◽  
pp. S219
Author(s):  
C.L. Morgan ◽  
S. Jenkins-Jones ◽  
A. Radwan ◽  
P. Conway ◽  
A. Reynolds ◽  
...  
Keyword(s):  
Liver Disease ◽  
Hepatic Encephalopathy ◽  
Severe Liver ◽  
Severe Liver Disease

scholarly journals PTU-126 Mortality Associated With Hepatic Encephalopathy In Patients With Severe Liver Disease

Gut ◽  
2014 ◽  
Vol 63 (Suppl 1) ◽  
pp. A94.1-A94 ◽  
Author(s):  
CL Morgan ◽  
S Jenkins-Jones ◽  
A Radwan ◽  
P Conway ◽  
CJ Currie
Keyword(s):  
Liver Disease ◽  
Hepatic Encephalopathy ◽  
Severe Liver ◽  
Severe Liver Disease

scholarly journals PTU-127 Resource Use Associated With Hepatic Encephalopathy In Patients With Severe Liver Disease

Gut ◽  
2014 ◽  
Vol 63 (Suppl 1) ◽  
pp. A94.2-A95 ◽  
Author(s):  
J Orr ◽  
CL Morgan ◽  
M Hudson ◽  
S Jenkins-Jones ◽  
P Conway ◽  
...  
Keyword(s):  
Liver Disease ◽  
Hepatic Encephalopathy ◽  
Resource Use ◽  
Severe Liver ◽  
Severe Liver Disease

scholarly journals Μελέτη της αιμοδυναμικής του εγκεφάλου με τη βοήθεια της διακρανιακής doppler υπερηχογραφίας (transcranial doppler ultrasonography - TCD) σε ασθενείς με χρόνια ηπατική νόσο

2010 ◽  
Author(s):  
Ελένη Μόκα
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Liver Disease ◽  
Hepatic Encephalopathy ◽  
Chronic Liver ◽  
Cerebral Oximetry ◽  
Cross Sectional ◽  
Cirrhotic Patients ◽  
Blood Flow Velocities ◽  
Flow Velocities

BackgroundCerebral haemodynamic and metabolic derangement is well known and common in patients withchronic liver disease or / and cirrhosis. It is often manifested as hepatic encephalopathy, although itscause and pathogenesis are not clearly understood and poorly elucidated. Patients with cirrhosisusually show alterations of cerebral perfusion and oxygenation, as well as changes of systemichaemodynamics and are thus prone to develop arterial hypotension, which might result in brainhypoperfusion, if cerebral autoregulation is impaired. Transcranial Doppler and Cerebral Oximetryare non invasive methods of neurological monitoring and are broadly used in the evaluation of theintracranial circulation and cerebral oxygenation status.Study Aims and ObjectivesThe aim of this open, comparative, non randomized, cross – sectional and longitudinal,observational clinical study was to evaluate brain haemodynamics in patients with chronic liverdisease and to test the degree of impairment of their cerebral autoregulatory mechanism, by usingTranscranial Doppler Ultrasonography. In addition, one of our basic scopes was to compare theseresults with those from Cerebral Oximetry and correlate them with the levels of blood S100bprotein.Material and MethodsOur study consisted of 40 healthy volunteers (Group I) and 40 patients with chronic liver disease(Group II). From those with chronic hepatic disease, 33 had liver cirrhosis (Group IIa) and 7 justchronic liver disease without cirrhosis (Group IIb). Regarding cerebral haemodynamics the baselineparametres that were examined included cerebral blood flow velocities, Vsyst, Vdias, Vmean,Pulsatility and Resistive Indices (PI &RI), as well as rSO2 values from Cerebral Oximetry. All thesevalues were recorded and studied bilaterally. The evaluation of the cerebral autoregulatorymechanism was performed with the continuous monitoring of mean arterial blood pressure, as wellas of the cerebral blood flow velocities, in the middle cerebral artery, bilaterally, during passivemovements of Trendelenbourg and Reverse Trendelenbourg, at 45ο, sequentially. The cerebralability of altering its perfusion and metabolism status was checked, again bilaterally, with themeasurement of the parametres mentioned above, after 1 min of active and passive movement ofthe right and left elbow and hand, with one movement happening after the other. All themeasurements mentioned above, were also evaluated in the subgroups of cirrhotic patients, with orwithout hepatic encephalopathy, with or without portal hypertension and according to the Child –Pugh stage of the disease. In all the subjects that were tested basic cardiorespiratory parametreswere recorded, at predetermined checking time – points. Finally, blood samples were withdrawnfrom both patients and healthy volunteers for investigation of basic haematological and biochemicalparametres, analysis of arterial blood gases and determination of the S100b protein blood levels.ResultsDuring the cross – sectional phase of our study, the cerebral blood flow velocities were found to belower in patients with chronic liver disease, when compared to healthy volunteers, without anysignificant differences between patients with or without cirrhosis. In addition, regarding TCDvelocities, important deviations were noticed in between cirrhotic patients of various stages, withthe detection of the lowest values in those of Child – Pugh Stage C. Furthermore, we foundstatistically significant differences, bilaterally, in between cirrhotic patients with or without hepaticencephalopathy, but without any strong correlation to its stage. PI and RI were significantly higher inpatients with cirrhosis than in controls and non – cirrhotic patients with chronic hepatic disease.Hepatic Encephalopathy patients were characterized by higher cerebral vascular resistance, compared to cirrhotic patients without any cerebral derangement. Similar results wereextrapolated from the Cerebral Oximetry measurements, with the lowest values of rSO2 beingdetected in patients of Child – Pugh Stage C and in those with hepatic encephalopathy also of Stage3. PI and RI were significantly correlated with the severity of cirrhosis and the existence of hepaticencephalopathy. In addition, they were significantly correlated with blood ammonia levels, PT andserum levels of albumin and bilirubin. Both Vmean and rSO2, as well as PI and RI were stronglycorrelated with S100b blood levels. In subjects with the highest values of S100b, the lowest values ofVmean and rSO2 were measured, whereas the highest PI and RI were calculated.During the longitudinal phase of our study, which refers to the autoregulatory mechanism testing,the following were noticed. Head down or head up provoked an increase or drop in blood pressurerespectively in all the subjects that were examined. Healthy controls and non cirrhotic patients had aprompt recovery of Vmean and a progressive recovery of arterial pressure, so that, after 120 sec,both parametres had returned to baseline. At 20 sec the recovery of flow velocity was faster thanthat of blood pressure. By contrast, patients with cirrhosis had a delayed and incomplete recovery ofboth parametres. The recovery of mean velocity paralleled that of arterial pressure, indicating animpaired cerebral autoregulation. Regarding passive and active movements of elbows and hands,we noticed an ipsilateral and contralateral increase of blood flow velocities and cerebral Oximetryvalues, but without any statistically significant differences between control subjects and chronichepatic patients, or their subgroups.ConclusionsThe results of this cross sectional and longitudinal study indicate that cerebral blood flow velocitiesand cerebral oximetry values are decreased in patients with chronic liver disease, whereas PI and RIare elevated, in strong correlation with the liver failure stage, the cirrhosis stage and the presence ofhepatic encephalopathy. This conclusion becomes more powerful when we take into account thestrong correlation of the measured indices and the levels of S100b protein. Cerebral autoregulationmechanism is often impaired in chronic hepatic patients, especially those with decompensatedcirrhosis. These patients can easily develop cerebral hypoperfusion, if arterial pressure falls abruptly.TCD Ultrasonography and Near Infrared Spectroscopy (Cerebral Oximetry) provide real time anduseful indices to assess and monitor cirrhotic patients and subjects with chronic liver failure.

Sign in / Sign up

Export Citation Format

Share Document